Insulet | المديونيات المتداولة



Current Liabilities تغيير تاريخ
Abbott USD 13.44B 435M 2025-06
Align Technology USD 2B 4.54M 2025-06
AtriCure USD 68.84M 7.62M 2025-06
Avanos Medical USD 134.6M 2.6M 2025-06
Baxter International USD 3.48B 3.03B 2025-03
Becton, Dickinson and Co. USD 8.16B 469M 2025-06
Boston Scientific USD 5.06B 1.34B 2025-03
Cardinal Health USD 38.9B 2.24B 2025-06
Cooper Companies USD 1.01B 12.9M 2025-04
Dexcom USD 3.31B 271.6M 2025-06
Edwards Lifesciences USD 1.39B 110.4M 2025-03
Eli Lilly USD 39.02B 8.95B 2025-06
Globus Medical USD 424.66M 39.96M 2025-06
ICU Medical USD 482.78M 66.25M 2025-06
Insulet USD 1.01B 489.7M 2025-06
Integra LifeSciences USD 929.81M 11.35M 2025-06
J&J USD 56.9B 6.58B 2025-03
Masimo USD 592.1M 45.6M 2025-06
Medtronic USD 12.88B 1.04B 2025-04
Merit Medical Systems USD 225.57M 28.75M 2025-06
Roche Holding CHF 27.02B 424M 2024-12
Solventum Corp 2.62B 54M 2025-06
Stryker USD 7.29B 641M 2025-06
Tandem Diabetes Care USD 251.69M 36.48M 2025-06
Teleflex USD 716.15M 40.24M 2025-06
West Pharmaceutical Services USD 604.6M 77.9M 2025-06
Zimmer Biomet Holdings USD 2.7B 404.6M 2025-06


Insulet المديونيات المتداولة - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.